Thomas C Pearson
Overview
Explore the profile of Thomas C Pearson including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
57
Citations
1932
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Karadkhele G, Duneton C, Garro R, Badell I, Pearson T, Larsen C, et al.
Clin Transplant
. 2021 Nov;
36(3):e14531.
PMID: 34757651
The adoption of de novo belatacept in kidney transplant (kTx) recipients was hampered by an increased risk of acute cellular rejection (ACR) with variation in adopted belatacept based immunosuppressive therapies...
2.
Englesbe M, Pearson T
Am J Transplant
. 2020 Aug;
21(3):923-924.
PMID: 32738162
No abstract available.
3.
Karadkhele G, Hogan J, Magua W, Zhang W, Badell I, Mehta A, et al.
Am J Transplant
. 2020 Jun;
21(1):208-221.
PMID: 32519434
Introduction: Cytomegalovirus (CMV) remains associated with poor outcomes after kidney transplantation (kTx). The impact of belatacept on CMV infection remains understudied. In this study, we assessed the impact of belatacept...
4.
Parsons R, Larsen C, Pearson T, Badell I
Curr Transplant Rep
. 2020 Mar;
6(4):277-284.
PMID: 32158639
Purpose Of Review: Highlight developments in T and B cell biology that are helping elucidate the mechanisms underlying CD28 pathway blockade-mediated inhibition of alloantibodies in transplantation, and discuss recent clinical...
5.
Parsons R, Zahid A, Bumb S, Decker H, Sullivan H, Lee F, et al.
Am J Transplant
. 2019 Aug;
20(2):573-581.
PMID: 31452332
Recent evidence suggests that belatacept reduces the durability of preexisting antibodies to class I and class II human leukocyte antigens (HLAs). In this case series of 163 highly sensitized kidney...
6.
Delwiche S, Pearson T, Brabec D
Plant Dis
. 2019 Feb;
89(11):1214-1219.
PMID: 30786446
Fusarium head blight (FHB) is a fungal disease that affects small cereal grains, such as wheat and barley, and is becoming more prevalent throughout much of the world's temperate climates....
7.
Gangappa S, Wrammert J, Wang D, Li Z, Liepkalns J, Cao W, et al.
Transpl Immunol
. 2019 Jan;
53:51-60.
PMID: 30664927
Annual vaccination is routinely used in organ transplant recipients for immunization against seasonal influenza. However, detailed analysis of the kinetics of vaccine-induced immune responses in this population is lacking. In...
8.
Basu M, Petgrave-Nelson L, Smith K, Perryman J, Clark K, Pastan S, et al.
Clin J Am Soc Nephrol
. 2018 Mar;
13(4):620-627.
PMID: 29581107
Background And Objectives: Barriers exist in access to kidney transplantation, where minority and patients with low socioeconomic status are less likely to complete transplant evaluation. The purpose of this study...
9.
Weir M, Pearson T, Patel A, Peddi V, Kalil R, Scandling J, et al.
Transplantation
. 2016 Mar;
101(1):157-165.
PMID: 26950714
In the Spare-the-Nephron (STN) Study, kidney transplant recipients randomized about 115 days posttransplant to convert from CNI (calcineurin inhibitor)/MMF to sirolimus (SRL)/MMF had a significantly greater improvement in measured GFR...
10.
Vitiello G, Sayed B, Wardenburg M, Perez S, Keith C, Canter D, et al.
J Am Soc Nephrol
. 2015 Dec;
27(7):2157-63.
PMID: 26701982
Screening recommendations for prostate cancer remain controversial, and no specific guidelines exist for screening in renal transplant candidates. To examine whether the use of prostate-specific antigen (PSA)-based screening in patients...